ONCY Latest Press Releases

-- January 15, 2026 --

Oncolytics Biotech Announces Results of Special Meeting of Shareholders Globe Newswire 4:01 PM

-- January 14, 2026 --

The $185B Cancer Surge: Why the FDA's Fast-Track Pivot is Scaling a New Immunotherapy Era Globe Newswire 10:40 AM

THE SOVEREIGN MANDATE: 5 Stocks Securing the 2026 Choke Points Globe Newswire 10:15 AM

Oncolytics Biotech Appoints John McAdory as EVP of Strategy and Operations and Yujun Wu to Lead Biostatistics Globe Newswire 9:00 AM

-- January 12, 2026 --

The $225B Precision Sprint: How Big Pharma is Beating the $170B Patent Cliff Globe Newswire 10:14 AM

Oncolytics Biotech Announces Updated Clinical Data from GOBLET Cohort 4 Demonstrating Activity of Pelareorep Plus Atezolizumab in Third-Line Anal Cancer Globe Newswire 9:00 AM

-- January 9, 2026 --

Oncolytics Biotech Outlines Strategic Rationale for Proposal to Change Jurisdiction of Incorporation to Nevada Globe Newswire 9:00 AM

-- January 8, 2026 --

The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech Globe Newswire 12:08 PM

Oncolytics Biotech Provides Update on Intellectual Property Strategy and Patent Filings Business Wire 9:00 AM

-- January 7, 2026 --

THE CHOKE POINT: 5 Assets That Control the Bottleneck Globe Newswire 12:15 PM

Oncolytics Biotech Expands Its Gastrointestinal Tumor Scientific Advisory Board with the Addition of Dr. Eileen O'Reilly, Dr. Neil Segal, and Dr. Van Morris Business Wire 9:00 AM

-- December 16, 2025 --

Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards Globe Newswire 12:18 PM

Oncolytics Biotech Announces Promising Efficacy and Translational Data Supporting Pelareorep in KRAS-Mutant Metastatic Colorectal Cancer Business Wire 9:00 AM

-- December 15, 2025 --

THE VISIBILITY INDEX: 5 Companies Solving the Invisible Crisis Globe Newswire 10:54 AM

-- December 12, 2025 --

Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance PRNewswire 10:48 AM

GI Cancer Immunotherapy Breakthroughs Signal New Treatment Era Globe Newswire 10:31 AM

-- December 9, 2025 --

Oncolytics Biotech Reschedules Special Meeting of Shareholders to Change Jurisdiction of Incorporation to Nevada Business Wire 6:00 PM

-- December 6, 2025 --

THE EFFICIENCY PARADOX: 5 Market Anomalies Trading Below Reality Globe Newswire 1:51 PM

-- December 3, 2025 --

UPDATE -- The Efficiency Gap: Five Assets Where Price Has Yet To Reflect Reality Globe Newswire 3:31 PM

The Efficiency Gap: Five Assets Where Price Has Yet To Reflect Reality Globe Newswire 12:51 PM

-- November 20, 2025 --

Oncolytics Biotech Provides Update on Special Meeting of Shareholders Business Wire 4:05 PM

-- November 19, 2025 --

Targeted Cancer Therapies Gain Momentum as Precision Market Surges Past $106B Globe Newswire 9:45 AM

Oncolytics Biotech Aligns with FDA on Pivotal Study Design for Pelareorep in First-Line Pancreatic Cancer Business Wire 9:00 AM

-- November 4, 2025 --

Oncolytics Biotech Establishes Gastrointestinal Tumor Scientific Advisory Board to Advance Pelareorep as a Platform Immunotherapy Business Wire 8:00 AM

-- October 28, 2025 --

Oncolytics Biotech Reports Updated Anal Cancer Data Showing Objective Response Rate More Than Double the Current Standard of Care PRNewswire 7:30 AM

-- October 20, 2025 --

Oncolytics Biotech Files Circular/Prospectus for Special Meeting of Shareholders To Change Jurisdiction of Incorporation to Nevada PRNewswire 9:01 AM

-- September 29, 2025 --

Oncolytics Biotech Announces Update for Potential First-Line Pancreatic Cancer Registration Study PRNewswire 8:31 AM

-- September 16, 2025 --

Oncolytics Biotech Provides Update on GOBLET Study Progress and U.S. Site Expansion PRNewswire 7:00 AM

-- September 8, 2025 --

Oncolytics Biotech Highlights Strong Efficacy and Translational Data in Metastatic Colorectal Cancer; Will Advance Regulatory Pathway Discussions PRNewswire 7:00 AM

-- September 2, 2025 --

Oncolytics Biotech Provides Updated Clinical Safety Data for Pelareorep, Including Across Multiple Gastrointestinal Tumors PRNewswire 9:10 AM

-- August 28, 2025 --

Oncolytics Biotech Announces Upcoming Investor Conferences in September PRNewswire 8:30 AM